One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Effects of the Million Hearts Model on Myocardial Infarctions, Strokes, and Medicare Spending
Laura Blue, PhD1; Keith Kranker, PhD1; Amanda R. Markovitz, ScD2; Rhea E. Powell, MD, MPH3; Malcolm V. Williams, PhD, MPP4; Jia Pu, PhD5; David J. Magid, MD, MPH6; Nancy McCall, ScD1; Allison Steiner, MPH2; Kate A. Stewart, SM, PhD7; Julia M. Rollison, MPH, PhD8; Patricia Markovich, PhD9; G. Greg Peterson, MPA, PhD1
doi : 10.1001/jama.2023.19597
October 17, 2023, Vol 330, No. 15, Pages 1409-1499
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
Teresa Coelho, MD, PhD1; Wilson Marques Jr, MD, PhD2; Noel R. Dasgupta, MD3; Chi-Chao Chao, MD, PhD4; Yeşim Parman, MD5; Marcondes Cavalcante França Jr, MD, PhD6; Yuh-Cherng Guo, MD7; Jonas Wixner, MD, PhD8; Long-Sun Ro, PhD9; Cristian R. Calandra, MD10; Pedro A. Kowacs, MD11; John L. Berk, MD12; Laura Obici, MD13; Fabio A. Barroso, MD14; Markus Weiler, MD15; Isabel Conceição, MD16; Shiangtung W. Jung, PhD17; Gustavo Buchele, PhD17; Michela Brambatti, MD17; Jersey Chen, MD, MPH18; Steven G. Hughes, MBBS17; Eugene Schneider, MD17; Nicholas J. Viney, BSc17; Ahmad Masri, MD19; Morie R. Gertz, MD20; Yukio Ando, MD21; Julian D. Gillmore, PhD22; Sami Khella, MD23; P. James B. Dyck, MD20; Márcia Waddington Cruz, PhD24; for the NEURO-TTRansform Investigators
doi : 10.1001/jama.2023.18688
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease
Stephen P. Juraschek, MD, PhD1; Jiun-Ruey Hu, MD, MPH2; Jennifer L. Cluett, MD1; Anthony M. Ishak, PharmD1,3; Carol Mita, MLIS4; Lewis A. Lipsitz, MD1,5; Lawrence J. Appel, MD, MPH6; Nigel S. Beckett, MB, ChB7; Ruth L. Coleman, MSc8; William C. Cushman, MD9; Barry R. Davis, MD, PhD10; Greg Grandits, MS11; Rury R. Holman, MB, ChB8; Edgar R. Miller 3rd, MD, PhD6; Ruth Peters, PhD, MSc12,13,14; Jan A. Staessen, MD, PhD15,16; Addison A. Taylor, MD, PhD17; Lutgarde Thijs, MSc18; Jackson T. Wright Jr, MD, PhD19; Kenneth J. Mukamal, MD, MPH, MA1
doi : 10.1001/jama.2023.18497
Reported Risky Alcohol Use Among US Adults Prescribed 3 Classes of Chronic Alcohol–Interactive Medications
Eden Y. Bernstein, MD1; Travis P. Baggett, MD, MPH1; Timothy S. Anderson, MD, MAS2
doi : 10.1001/jama.2023.16641
The Protein Structure Prediction Revolution and Its Implications for Medicine
John Jumper, PhD1; Demis Hassabis, PhD1
doi : 10.1001/jama.2023.17095
Optical Coherence Tomography—History, Evolution, and Future Prospects
James G. Fujimoto, PhD1; Eric A. Swanson, MS2; David Huang, MD, PhD3
doi : 10.1001/jama.2023.16942
A Commitment to Making Health Care Personal
David M. Spiro, MD, MPH1,2
doi : 10.1001/jama.2023.18037
Million Hearts Cardiovascular Disease Risk Reduction Model
Gabriel S. Tajeu, DrPH, MPH1; Karen Joynt Maddox, MD, MPH2,3; LaPrincess C. Brewer, MD, MPH5
doi : 10.1001/jama.2023.16096
Novel Treatments for Hereditary ATTRv Amyloidosis
Alejandra González-Duarte, MD, MSc1
doi : 10.1001/jama.2023.15087
Treating Hypertension in Patients With Orthostatic Hypotension
James Brian Byrd, MD, MS1; John D. Bisognano, MD, PhD1; Robert D. Brook, MD2
doi : 10.1001/jama.2023.19096
Hyperthyroidism
Sun Y. Lee, MD, MSc1; Elizabeth N. Pearce, MD, MSc1
doi : 10.1001/jama.2023.19052
The Use of Historical Controls in Clinical Trials
Joe D. Marion, PhD1; Andrew D. Althouse, PhD2,3
doi : 10.1001/jama.2023.16182
Uterine Prolapse
Oluwateniola E. Brown, MD1; Tsung P. Mou, MD2; Mary F. Ackenbom, MD, MSc3
doi : 10.1001/jama.2023.16277
Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug?
Rita Rubin, MA
doi : 10.1001/jama.2023.14443
The Promise and Pitfalls of AI in the Complex World of Diagnosis, Treatment, and Disease Management
Rebecca Voelker, MSJ
doi : 10.1001/jama.2023.19180
Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months
Rita Rubin, MA
doi : 10.1001/jama.2023.19759
C difficile Cross-Transmission in US ICUs May Be Rare, Study Suggests
Emily Harris
doi : 10.1001/jama.2023.18740
NIH Launches Phase 1 Trial of Broader “Universal� Flu Vaccine
Emily Harris
doi : 10.1001/jama.2023.18741
Systematic Review Finds the Most Effective Smoking Cessation Aids
Emily Harris
doi : 10.1001/jama.2023.18742
Wastewater Surveillance Predicts Large-Scale Flu, RSV Trends
Emily Harris
doi : 10.1001/jama.2023.18743
Most People With GERD Don’t Have Increased Esophageal Cancer Risk
Emily Harris
doi : 10.1001/jama.2023.18744
Air Pollution Tied With Increased Chance of Breast Cancer
Emily Harris
doi : 10.1001/jama.2023.18745
4.5 Billion People Lack Coverage for Essential Health Services
Emily Harris
doi : 10.1001/jama.2023.18747
Nonprescription Heartburn Medications for Adults
Sarah E. Vordenberg, PharmD, MPH1
doi : 10.1001/jama.2023.16280
Vitamin K Antagonists and Intracranial Hemorrhage After Endovascular Thrombectomy
Arosh S. Perera Molligoda Arachchige, MD1
doi : 10.1001/jama.2023.15434
Vitamin K Antagonists and Intracranial Hemorrhage After Endovascular Thrombectomy—Reply
Brian Mac Grory, MB, BCh1; Ying Xian, MD, PhD2
doi : 10.1001/jama.2023.15437
Postacute Sequelae of SARS-CoV-2 Infection
Ayush Batra, MD1; Avindra Nath, MD2; Igor J. Koralnik, MD1
doi : 10.1001/jama.2023.15709
Postacute Sequelae of SARS-CoV-2 Infection—Reply
Tanayott Thaweethai, PhD1; Andrea S. Foulkes, ScD1
doi : 10.1001/jama.2023.15712
Ethical Concerns for Amnioinfusions
Meredith A. Atkinson, MD, MHS1; Jena L. Miller, MD2
doi : 10.1001/jama.2023.15927
Ethical Concerns for Amnioinfusions—Reply
Omri D. Soffer, MD1; Teri J. Mauch, MD, PhD2; Melissa A. Muff-Luett, MD2
doi : 10.1001/jama.2023.15930
